Stockreport

Enlivex Therapeutics Provides Clinical Update on Positive Safety Profile of Its Off-The-Shelf Cell Therapy Product in First Three Severe Sepsis Patients

Enlivex Therapeutics Ltd. - Ordinary Shares  (ENLV) 
PDF Nes Ziona, Israel, June 06, 2019 (GLOBE NEWSWIRE) --  Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today provided a clinical updat [Read more]